|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
»óÀåÁ¦¾à»ç ºÐ¼®ÆÀ/ÀÓ»óÆÀ(2~5³â) 2¸í
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
2³â¡è |
ä¿ë½Ã |
11.25 |
|
|
JN Partners |
±Û·Î¹ú CRO PM/CTL(aPM)
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
05.25 |
|
|
JYpartners |
[[¾à»ç, ÇѾà»ç Çʼö]] CRA 2³â ÀÌ»ó °æ·ÂÀÚ OK
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
05.06 |
|
|
JN Partners |
[±Û·Î¹ú CRO ¿©·¯°÷] CRAÆ÷Áö¼Ç ¿©·¯°³
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
09.07 |
|
|
JN Partners |
[¹ÙÀÌ¿À»ç] CPM ÀçÅà ǮŸÀÓ/ ÆÄƮŸÀÓ /CPM role ÆÄÆ®º° ´ã
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
06.11 |
|
|
ÄÚ¸®¾ÆÇìµå |
¿Ü±¹°è Á¦¾à»ç CRA 2~4³â °æ·ÂÀÚ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
07.09 |
|
|
JN Partners |
[ÀÇ·á±â] ÀÓ»ó PM / CTA ¹× SSU °æ·ÂÀÚ Áö¿ø °¡´É
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
12.07 |
|
|
JN Partners |
[±Û·Î¹ú CRO] JR CRA / SR CRA / ¾÷¹«·Îµå ÁÁÀºÆí
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
06.29 |
|
|
(ÁÖ)ºê·£µå¹Ì |
±×·ì»ç Á¦¾àÀǾà ÀÓ»ó CRA
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
10.03 |
|
|
ÇÉÄ¿½ºÄÚ¸®¾Æ |
ÀÇ·á±â±â ÀÓ»ó½ÃÇè°ü¸®ÀÚ(CRA)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
03.30 |
|
|
JN Partners |
[¹ÙÀÌ¿À»ç] CPM ÀçÅà (ǮŸÀÓ/ ÆÄƮŸÀÓ)
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.26 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹Àû ¼±µÎÁ¦¾à»ç PV (Pharmacovigilance) Specialist
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
02.16 |
|
|
K1partners |
[±¹³»´ë±â¾÷Á¦¾à»ç] LPS CRA, Sr.CRA, PM(ÃÖ¼Ò °æ·Â 2³âÀÌ»ó
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
01.17 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Patient Safety Specialist(´ë¸®-°úÀå±Þ)/±Û·Î¹ú¿Ü±¹°èÁ¦¾à
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
JN Partners |
[±Û·Î¹úCRO] PMS CRA /CRC °æ·ÂÀÚ Áö¿ø °¡´É/ ÀçÅà ÁÖ 3ȸ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
08.13 |
|